AxoSim

AGINKO Research is the premiere CRO for preclinical work in osteoarticular pathologies. We offer a wide range of contract research services to support Drug and Medical Device established companies as well as start-ups and academia. From industry standard protocols to customized research design, our animal models and assays, both on an in vivo or in vitro basis, provide key tools for compound discovery and product development.

Given our expertise, know-how, and network in the field of osteoarticular pathologies, AGINKO today also offers a full range of histology services for your preclinical and clinical trials as well as general consulting services (e.g., regulatory, strategy, financing) devoted to osteoarticular pathologies.


#Osteoarticular #CRO #Cartilage #Repair #Arthritis #Fracture #Osteoporosis #Preclinical #Pain #Disc #Spine #Infection

BioCentrum's mission is to create a platform for our clients and partners in order to help them translate innovative discoveries into preclinical candidates with improved chances to become marketed in the least amount of time possible. Our offer is a range of in vitro and in vivo assays that are created toward incorporating preclinical information into your pipeline.

BioCentrum's mission is to create a platform for our clients and partners in order to help them translate innovative discoveries into preclinical candidates with improved chances to become marketed in the least amount of time possible. Our offer is a range of in vitro and in vivo assays that are created toward incorporating preclinical information into your pipeline.

Call us today at +1.855.827.6968

Crown Bioscience, Inc. is a platform technology company providing drug discovery and development services in the areas of Oncology and Inflammation.
CrownBio helps biopharmaceutical companies solve some of today's most pressing challenges in oncology with an offering of end-to-end preclinical solutions, a unique collection of ready-to-run, well-validated in vitro, in vivo, and ex vivo models, and cutting-edge technologies.
Our Translational Platforms bring clarity to drug discovery and enable clients around the world to deliver superior clinical candidates.
CrownBio provides preclinical immunotherapy research platforms to support the successful transition of immunotherapeutics from the lab into the clinic including models for the evaluation of CAR-T therapies, syngeneics, and humanized models.
Our team of experts worldwide, comprising highly trained PhD and MS scientists, provides services to Pharmaceutical, Biotechnology companies, and Biomedical Research Institutes around the world.

Dabur Research Foundation (DRF) is an Indian Contract Research Organization Est.1979 offering preclinical services in Drug Discovery and Development, ranging from identification of potential lead molecules, drug development to IND enabling studies. We offer preclinical services to global Biotech, Pharma, Phytopharmaceuticals Cosmeceuticals and academia sectors.
Our services broadly fall into the functional areas of In Vitro, Ex-Vivo & In Vivo Pharmacology, Exploratory & GLP Toxicology & DMPK. Our genesis is from the Dabur group of companies; we started operating as a preclinical service provider after a strategy spin-off from our parent company in the year 2008. It is this experience of 30 years of drug discovery & development that we bring to our clients as a preclinical service provider.